MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors

Advances in the use of targeted and immune therapies have revolutionized the clinical management of melanoma patients, prolonging significantly their overall and progression-free survival. However, both targeted and immune therapies suffer limitations due to genetic mutations and epigenetic modifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Motti, Maria Letizia, Minopoli, Michele, Di Carluccio, Gioconda, Ascierto, Paolo Antonio, Carriero, Maria Vincenza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352536/
https://www.ncbi.nlm.nih.gov/pubmed/32604720
http://dx.doi.org/10.3390/ijms21124544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352536/
https://www.ncbi.nlm.nih.gov/pubmed/32604720
http://dx.doi.org/10.3390/ijms21124544

Ejemplares similares